Search research articles
Contact Us
Filters
Showing results (91-100 of 120) with videos related to
Page
of 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2025
Pancreatic cancer organoids recapitulate chemotherapy response and identify a potent cytotoxic T cell population
Renee R Anderko, Alexandra E Bowman, Praneel Murthy, et al.
Journal of Surgical Education
|
December 27, 2024
Biotissue Curriculum Translates to Performance in the Operating Room for Gastrojejunostomy and Hepaticojejunostomy in Robotic Pancreaticoduodenectomy
Jasmine D Kraftician, Kristine Kuchta, Mazen S Zenati, et al.
Annals of Surgical Oncology
|
November 4, 2025
KRAS Mutation Allele Frequency Dynamics in Plasma Extracellular Vesicles: Association with Survival in Localized Pancreatic Adenocarcinoma
Asmita Chopra, Hong-Zhang He, Jadranka Milosevic, et al.
The British Journal of Surgery
|
February 19, 2025
Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort study
Esther N Dekker, David van Klaveren, Eva M M Verkolf, et al.
Cancer Medicine
|
September 24, 2021
Encouraging long-term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high-risk patients with resectable pancreatic carcinoma
Samer S AlMasri, Mazen S Zenati, Annissa Desilva, et al.
Annals of Surgical Oncology
|
November 24, 2020
Outcomes of Neoadjuvant Chemotherapy Versus Chemoradiation in Localized Pancreatic Cancer: A Case-Control Matched Analysis
Asmita Chopra, Jacob C Hodges, Adam Olson, et al.
Journal of the National Cancer Institute
|
March 20, 2026
Restaging after neoadjuvant FOLFIRINOX for localized pancreatic cancer: a clinical calculator from the Trans-Atlantic Pancreatic Surgery consortium
Esther N Dekker, David van Klaveren, Eva M M Verkolf, et al.
Journal of Surgical Oncology
|
December 31, 2025
Pretreatment CA19-9 Predicts Survival in Pancreatic Cancer With Optimal Response to Neoadjuvant Therapy
Anthony Gebran, Asmita Chopra, Emile Farah, et al.
Journal of the National Cancer Institute
|
February 14, 2022
FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium
Quisette P Janssen, Jacob L van Dam, Deesje Doppenberg, et al.
Annals of Surgery
|
November 17, 2020
Significance of Uncinate Duct Dilatation in IPMNs: A New High-risk Criterion?
Samer S AlMasri, Mazen S Zenati, Anil Dasyam, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 120) with videos related to
Sort By:
Page
of 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2025
Pancreatic cancer organoids recapitulate chemotherapy response and identify a potent cytotoxic T cell population
Renee R Anderko, Alexandra E Bowman, Praneel Murthy, et al.
Journal of Surgical Education
|
December 27, 2024
Biotissue Curriculum Translates to Performance in the Operating Room for Gastrojejunostomy and Hepaticojejunostomy in Robotic Pancreaticoduodenectomy
Jasmine D Kraftician, Kristine Kuchta, Mazen S Zenati, et al.
Annals of Surgical Oncology
|
November 4, 2025
KRAS Mutation Allele Frequency Dynamics in Plasma Extracellular Vesicles: Association with Survival in Localized Pancreatic Adenocarcinoma
Asmita Chopra, Hong-Zhang He, Jadranka Milosevic, et al.
The British Journal of Surgery
|
February 19, 2025
Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort study
Esther N Dekker, David van Klaveren, Eva M M Verkolf, et al.
Cancer Medicine
|
September 24, 2021
Encouraging long-term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high-risk patients with resectable pancreatic carcinoma
Samer S AlMasri, Mazen S Zenati, Annissa Desilva, et al.
Annals of Surgical Oncology
|
November 24, 2020
Outcomes of Neoadjuvant Chemotherapy Versus Chemoradiation in Localized Pancreatic Cancer: A Case-Control Matched Analysis
Asmita Chopra, Jacob C Hodges, Adam Olson, et al.
Journal of the National Cancer Institute
|
March 20, 2026
Restaging after neoadjuvant FOLFIRINOX for localized pancreatic cancer: a clinical calculator from the Trans-Atlantic Pancreatic Surgery consortium
Esther N Dekker, David van Klaveren, Eva M M Verkolf, et al.
Journal of Surgical Oncology
|
December 31, 2025
Pretreatment CA19-9 Predicts Survival in Pancreatic Cancer With Optimal Response to Neoadjuvant Therapy
Anthony Gebran, Asmita Chopra, Emile Farah, et al.
Journal of the National Cancer Institute
|
February 14, 2022
FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium
Quisette P Janssen, Jacob L van Dam, Deesje Doppenberg, et al.
Annals of Surgery
|
November 17, 2020
Significance of Uncinate Duct Dilatation in IPMNs: A New High-risk Criterion?
Samer S AlMasri, Mazen S Zenati, Anil Dasyam, et al.
Page
of 12